Literature DB >> 25862066

Molecular epidemiology, and possible real-world applications in breast cancer.

Hidemi Ito1, Keitaro Matsuo2,3.   

Abstract

Gene-environment interaction, a key idea in molecular epidemiology, has enabled the development of personalized medicine. This concept includes personalized prevention. While genome-wide association studies have identified a number of genetic susceptibility loci in breast cancer risk, however, the application of this knowledge to practical prevention is still underway. Here, we briefly review the history of molecular epidemiology and its progress in breast cancer epidemiology. We then introduce our experience with the trial combination of GWAS-identified loci and well-established lifestyle and reproductive risk factors in the risk prediction of breast cancer. Finally, we report our exploration of the cumulative risk of breast cancer based on this risk prediction model as a potential tool for individual risk communication, including genetic risk factors and gene-environment interaction with obesity.

Entities:  

Keywords:  Breast cancer; Cancer; GWAS; Genome-wide association study; Molecular epidemiology

Mesh:

Year:  2015        PMID: 25862066     DOI: 10.1007/s12282-015-0609-8

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  10 in total

1.  The more from East-Asian, the better: risk prediction of colorectal cancer risk by GWAS-identified SNPs among Japanese.

Authors:  Makiko Abe; Hidemi Ito; Isao Oze; Masatoshi Nomura; Yoshihiro Ogawa; Keitaro Matsuo
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-28       Impact factor: 4.553

Review 2.  Long Non-coding RNA ZFPM2-AS1: A Novel Biomarker in the Pathogenesis of Human Cancers.

Authors:  Gabriel B K Sasa; Cheng Xuan; Guoliang Lyu; Xianfeng Ding; Fang Meiyu
Journal:  Mol Biotechnol       Date:  2022-01-31       Impact factor: 2.695

3.  MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway.

Authors:  Jun Huang; Yinyin Qin; Canfeng Lin; Xiaoguang Huang; Feiran Zhang
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

4.  Bisphosphonate-related osteonecrosis of the jaw in metastatic breast cancer patients: a review of 25 cases.

Authors:  Hong-Joon Kim; Tae-Jun Park; Kang-Min Ahn
Journal:  Maxillofac Plast Reconstr Surg       Date:  2016-02-01

Review 5.  Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer therapy.

Authors:  Rama Rao Malla; Batoul Farran; Ganji Purnachandra Nagaraju
Journal:  World J Biol Chem       Date:  2021-03-27

6.  MiRNA-186-5p Exerts an Anticancer Role in Breast Cancer by Downregulating CXCL13.

Authors:  Yulong Wang; Shaojun Hu; Hongbin Zhang; Chenxin Zhang; Qixin Lian; Yu Jiao; Yu Zhou
Journal:  J Healthc Eng       Date:  2022-02-25       Impact factor: 2.682

7.  MiR-1270 Suppresses the Malignant Progression of Breast Cancer via Targeting MMD2.

Authors:  Shaojun Hu; Yang Song; Yu Zhou; Yu Jiao; Song Wang
Journal:  J Healthc Eng       Date:  2022-03-19       Impact factor: 2.682

8.  Breast cancer pathogenesis is linked to the intra-tumoral estrogen sulfotransferase (hSULT1E1) expressions regulated by cellular redox dependent Nrf-2/NFκβ interplay.

Authors:  Aarifa Nazmeen; Guangping Chen; Tamal Kanti Ghosh; Smarajit Maiti
Journal:  Cancer Cell Int       Date:  2020-03-04       Impact factor: 5.722

9.  17‑AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA‑MB‑231 breast cancer cells.

Authors:  Yu Zuo; Heng Xu; Zhifeng Chen; Fengmin Xiong; Bei Zhang; Kaixian Chen; Hualiang Jiang; Cheng Luo; Hao Zhang
Journal:  Oncol Rep       Date:  2020-03-26       Impact factor: 3.906

10.  Significance of Some Non-Invasive Biomarkers in the Early Diagnosis and Staging of Egyptian Breast Cancer Patients.

Authors:  Tarek Mk Motawi; Nadia I Zakhary; Hebatallah A Darwish; Hassan Abdullah; Samer A Tadros
Journal:  Asian Pac J Cancer Prev       Date:  2020-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.